Skip to content
You are now leaving to visit

Ionis announces appointment of Brett P. Monia Ph.D. to its board of directors

CARLSBAD, Calif. , March 25, 2019 /PRNewswire/ —  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, today announced that Brett P. Monia , Ph.D., has been appointed to the company’s board of directors. Dr. Monia currently serves as Ionis’ chief operating officer